Your Shopping Cart Is Empty
| Report Code: A08413 | Nov 2023 | Pages: NA | ||
| Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Bio-defense Market
Request Now !Bio-defense accounts for the use of various medical procedures that help in protecting individuals against bioterrorism, which involves not only drugs and vaccinations but also research and various health preparations for the population for defending themselves against such biological attacks. Bio-defenses are a combination of different systems and processes, which are put together in a place by bioscience laboratories, agricultural managers, customs agents, and other professionals to prevent the use of dangerous pathogens and toxins. Examples of these include the regulations that are imposed on the research carried out on certain pathogens, or preparatory plans for the case of a hostile disease outbreak. To build and maintain a successful bio-defense system, laboratories should have a mechanism methodology for the investigation of the outbreak and also a mechanism to prevent a biological attack. This mechanism should comprise primitive, secondary, and tertiary level prevention from the biological attacks.
COVID-19 scenario analysis:
Governments are taking various initiatives to enhance the readiness against chemical, biological, nuclear and radiological threats, advancements, and adoption through the technological perspective, gene chips being produced for pathogen detection in forensic division, database management systems, nanotechnology, and advanced detector hardware in bio-defense drug development. These are the major factors affecting the bio-defense market positively.
There has been a rise in the frequency of infectious diseases, such as influenza, that has spread a lot of awareness and encouraged pharmaceutical companies to work on R&D for such biological threats. Various programs are also conducted to improvise the scientific research of infectious diseases and create awareness within the public and encourage the population to use public health and be prepared for such biological attacks.
Additionally, the congenital Zika virus infection incidence has helped to boost the investments in the field of bio-defense. Nuclear or radiation weapons are capable of destruction due to their harmful effects, such as radiations, and cause damage equivalent to explosive bombs. To reduce the risk of bio attacks, governments across the world provide funding for medical countermeasures against the attacks to help the market growth positively. Moreover, there has been significant growth in the investments by governments in R&D in North America & European countries. Governments of the Asia-Pacific and Latin American countries are also working on new and favorable initiatives to develop their bio-defense systems. The upgrades in the technological aspect in the biotechnology sector in North America and Europe also contributes to the market growth.
On the other hand, the funding provided for manufacturing vaccines against bioterrorism attacks by authorities in developing and underdeveloped economies is considerably low and hampers the bio-defense market growth.
On August 8th, 2018, Emergent BioSolutions, Inc. took possession of PaxVax Holding Company Ltd., a developer and manufacturer of vaccines to fight against infectious diseases. In 2018, the U.S. government announced National Bio-defense Strategy and Implementation Plan, the National Defense Strategy, and the National Counterterrorism Strategy, the National Security Strategy, and the National Counter WMD Strategy to provide bio-defense and bio-security to the country. On January 27th, 2017, Emergent BioSolutions Inc. got an approval from the German Federal Ministry of Health, which allowed it to market BioThrax, which was an Anthrax vaccine.
The major consumers of the bio-defense market are the military and governments of any country. As the governments are closely looking upon the current and future policies and the activities to understand the bio-security and bio-defense threats & preventions, various pharmaceutical companies operating in the bio-defense market have considerable opportunities to expand and be prepared for any bioterrorism.
Key benefits of the report:
Questions answered in the bio-defense market research report:
Bio-defense Market: Global Opportunity Analysis and Industry Forecast 2020–2027 Report Highlights
| Aspects | Details |
|---|---|
| By Product |
|
| By Application |
|
| By End Users |
|
| By Region |
|
| Key Market Players | Bavarian Nordic, Elusys Therapeutics, Inc., Xoma Corporation, Dynavax Technologies Corporation, Cleveland Biolabs, Achaogen, Inc., SIGA Technologies, Inc., Alnylam Pharmaceuticals, Inc., PharmAthene, Inc., Emergent Bio-Solutions, Inc., Ichor Medical Systems, Nano therapeutics, Inc., Dynport Vaccine Company LLC |
Start reading.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report